PNPLA3 as a severity modifier and the susceptibility–progression distinction in Indian MASLD: response to Kaushal et al.

Journal of Clinical and Experimental Hepatology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles